Agatston 2.0 and AI-CVD unveiled in a new SCCT-hosted webcast, showcasing the next generation of calcium scoring and cardiometabolic imaging. HOUSTON, TX, UNITED STATES, November 20, 2025 / EINPresswire.com / -- The Society of Cardiovascular Computed Tomography (SCCT) and HeartLung.AI today announced the release of a new sponsored webcast, “Agatston 2.0: The next generation of calcium scoring in the era of AI-CAC and AI-CVD.” The free webcast, sponsored by HeartLung.AI , br

Hosted by Society of Cardiovascular Tomography (SCCT) Agatston 2.0: The next generation of calcium scoring in the era of AI-CAC and AI-CVD Full Video View Part 1 View Part 2 Webcast Summary Thirty years ago, the Agatston Score pioneered CT-based coronary atherosclerosis imaging. Since then, extensive evidence has established CAC as the strongest predictor of CHD events. However, two limitations have constrained its clinical utility: “Power of Zero” exceptions:  Alth

New Orleans, LA — October 21, 2025  — HeartLung Technologies today announced a record-setting presence at the upcoming American Heart Association (AHA) Scientific Sessions 2025, with nine peer-reviewed studies accepted for presentation—spotlighting breakthroughs from the company’s AI-CVD™ platform, including AI-CAC™ and novel CT-derived cardiometabolic imaging biomarkers. The work spans prediction of coronary “soft plaques”, heart failure, atrial fibrillation, COPD, non-zero

HOUSTON, TX —  The American Heart Association (AHA) has released an official Scientific Statement  in Circulation recognizing AI-enabled opportunistic detection of coronary artery calcium (CAC) on routine chest CT scans  as an emerging cornerstone for cardiovascular disease prevention . The statement, titled “Opportunistic Detection of Coronary Artery Calcium on Noncardiac Chest Computed Tomography: An Emerging Tool for Cardiovascular Disease Prevention,”  highlights the tr

October 07, 2025 I Louisville, KY – 3DR Labs, the nation’s largest and most trusted provider of 3D medical image post-processing, today...

FOR IMMEDIATE RELEASE New York, NY — October 1, 2025 AI-CVD investigators will join global experts at the International Early Lung Cancer...

HeartLung AI will showcase seven abstracts at ESC 2025 on AI-CVD™, including novel AI-CAC™ for earlier, more sensitive heart disease...

HOUSTON, TX, UNITED STATES, July 8, 2025 / EINPresswire.com / -- HeartLung.AI , a leader in AI-powered medical imaging solutions for...

HeartLung Technologies partners with Capitol Imaging Services to offer Artificial Intelligence-Enabled Osteoporosis Screening (AutoBMD™ AI and AutoChamber™ AI) as an add-on to CT Scans in Alabama.

Dr. Robert A. Kloner's latest musical endeavor, "Fillmore Station," is a blend of piano-based neo-classical and new age music.

CMS has approved a new HCPCS code for AutoChamber™ AI reporting cardiac chambers volume and left ventricular mass in existing CT scans.

HeartLung Technologies welcomes medical imaging and bioengineering expert Dr. Zahi A. Fayad, PHD, to the Advisory Board.

HeartLung showcases AI innovations at BMEII 2025, advancing healthcare with three scientific presentations.

HeartLung Technologies to launch AutoChamber™ AI at ACC 2025 and begin offering the AI services to healthcare providers

HeartLung Technologies Selected as a Finalist for ACC 2025 Innovation Pitch Challenge

SimonMed Imaging partners with HeartLung.AI to roll out AutoBMD™ AI for osteoporosis screening, enhancing preventive healthcare.

Experts at RSNA 2024 discuss AI's transformative impact on cardiovascular imaging, featuring insights from HeartLung.AI., Nurea, AI4MedImagi

Dr. Cheryl Healton, DrPH, emphasizes AI's role in public health, expanding lung screening, and managing smoking-related illnesses.

Panel highlights advanced imaging and AI in early disease detection, emphasizing standardized reporting and insurance for preventive measure

Dr. Susan K. Fried, PhD, highlights how sex and race differences in visceral fat impact cardiovascular disease and diabetes risk.